A critical breakthrough in cancer research is arising with the use of nanobodies to re-engage dysfunctional p53. This essential malignant protector protein is frequently lost in several forms of tumors, resulting https://bookmarkcitizen.com/story21930194/nanobodies-reactivate-tumor-suppressor-p53-the-potential-hope-for-cancer-management